AstraZeneca and the University of Oxford have rigged the clinical trial of their COVID-19 vaccine, ChAdox1 nCoV-19, to avoid capturing many potential life-altering adverse reactions that may occur from this experimental vaccine. ICAN’s legal team once again filed an emergency petition to stop this unethical conduct.
Unlike the clinical trials for Moderna and Pfizer’s vaccines for COVID-19, which are occurring in the United States, the current clinical trial for AstraZeneca’s COVID-19 vaccine is not under the direct authority of the FDA, since this clinical trial is not occurring in the United States.
News reports have indicated that AstraZeneca will be starting a new clinical trial in the United States for its COVID-19 vaccine that presumably will include a placebo control group. In the meantime, its current clinical trial occurring outside the United States persists in using a MenACWY vaccine as a control. As if that were not enough to rig this trial’s safety results, the study design for their vaccine, ChAdox1 nCoV-19, like the design of Pfizer’s vaccine, provides that, despite reviewing efficacy for at least 2 years, it will only capture “adverse events” for 1 month and “serious adverse events” for only 6 months after each dose.
Therefore, ICAN’s legal team has also filed a citizen petition and an emergency stay petition demanding that the clinical trial design for this vaccine be updated to require that all adverse reactions for the entire period of the clinical trial be tracked against a placebo control group. These petitions also demand that the number of participants in this trial be increased and that they be tested before and after injection for any T-cells to SARS-CoV-2. ICAN intends to take further legal action if its rational and sensible requests are not met.
Just as the pharmaceutical companies will never rest when it comes to promoting and selling their vaccine products, we will never rest in exposing the truth regarding these products.